Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 90779434 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | Kenneth I. Kohn |
Attorney Docket Number | 0614.00072 |
2021-06-17 | Application Filed |
2021-07-26 | Status: Live/Pending |
2021-09-03 | Transaction Date |
Owner: | ![]() |
Address | Suite 8500 One World Trade Center New York DE 10007 |
Legal Entity Type | Corporation |
Legal Entity State | DE |
![]() | MULTI | 2021-06-17 |
![]() | JPEG | 2021-06-17 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0441 | real-time monitoring of patient's physiological and behavioral state during psychedelic-assisted therapeutic session; digitalization of pre-session patient assessment and return to baseline patient assessment introduces precision, standardization and scalability into psychedelic-assisted therapy; system is automatically generating therapeutic session outcome reports for the clinician's interface |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-09-03 | 1 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2022-03-08 | 2 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2022-03-14 | 3 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2022-03-14 | 4 GNRT F:First Action |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2022-03-14 | 5 GNRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-08-02 | 6 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-08-02 | 7 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-08-02 | 8 TEME I:Incoming Correspondence |
NON-FINAL ACTION WRITTEN | 2022-08-18 | 9 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2022-08-18 | 10 GNRT O:Outgoing Correspondence |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2022-08-18 | 11 GNRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2023-02-15 | 12 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-02-15 | 13 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-02-15 | 14 TEME I:Incoming Correspondence |
NON-FINAL ACTION WRITTEN | 2023-03-17 | 15 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2023-03-17 | 16 GNRT O:Outgoing Correspondence |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2023-03-17 | 17 GNRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2023-06-07 | 18 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-06-07 | 19 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-06-07 | 20 TEME I:Incoming Correspondence |
NON-FINAL ACTION WRITTEN | 2023-07-06 | 21 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2023-07-06 | 22 GNRT O:Outgoing Correspondence |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2023-07-06 | 23 GNRN O:Outgoing Correspondence |
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | 2024-01-11 | 24 ABN2 O:Outgoing Correspondence |
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | 2024-01-11 | 25 MAB2 E:E-Mail |
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | 2024-01-12 | 26 MAB2 E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.